Clinical Trials Logo

Angle Closure Glaucoma clinical trials

View clinical trials related to Angle Closure Glaucoma.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05563623 Recruiting - Clinical trials for Angle-Closure Glaucoma

The Beijing Angle Closure Progression Study

Start date: August 4, 2022
Phase:
Study type: Observational

The Beijing angle closure progression study (BAPS) aims to explore the 5-year incidence of PACS progressing to PAC or PACG and to determine the possible risk factors of disease progression, which may provide the evidence for choosing the accurate strategies in the management of PACS.

NCT ID: NCT05163093 Recruiting - Clinical trials for Angle-Closure Glaucoma

Research on the Diagnosis and Treatment of Angle Closure Glaucoma With Abnormal Lens Zonular

Start date: November 1, 2020
Phase:
Study type: Observational

Angle-closure glaucoma is the main type of glaucoma in China, which is divided into acute and chronic angle-closure glaucoma. Previous studies from our group have found that, in lens excision combined with glaucoma surgery, accounted for 46.2% of patients were ligament abnormalities, such as lens subluxation with suspensory ligament relaxation. And it was more common in acute angle-closure glaucoma (55.8%). In acute angle-closure glaucoma, approximately 55.2% of suspensory ligament abnormalities were not diagnosed preoperatively depend on UBM and slit lamp examinations. The purpose of this study was to find a better preoperative diagnosis method of the suspensory ligament abnormality, and to observe the influence of the suspensory ligament abnormality on the occurrence, development and treatment effect of acute angle-closure glaucoma. We plan to collect patients with acute angle-closure glaucoma with monocular onset and exclude traumatic, secondary glaucoma and a history of intraocular surgery. The onset eyes were treated with combined operation, and divided into two groups according to the presence or absence of suspensory ligament abnormalities. The fellow eyes were treated with laser peripheral iridectomy, and followed examination, including UBM, anterior-segment OCT, and IOL master 700, before and after bow excitation test. Then follow up patients every six months. Ultimately, the fellow eyes will be treated with combined surgery after 2.5 years or the fellow eyes occur acute angle-closure glaucoma. In the end, we evaluate the sensitivity and specificity of each index, and the influence of suspensory ligament abnormality on angle-closure glaucoma progression.

NCT ID: NCT03626675 Recruiting - Glaucoma Clinical Trials

Anterior Segment Changes by Optical Coherence Tomography (OCT) in Phaco- Trabeculectomy

Start date: October 15, 2018
Phase: N/A
Study type: Interventional

1. Develop a measurement protocol by OCT imaging and characterization of the anterior chamber change in glaucoma patients before and after surgery. 2. Show the effect of combined surgery in control of intra ocular pressure.